Relationship of serum magnesium concentration to risk of short-term outcome of acute ischemic stroke

Blood Pressure

Volumn 22, Issue 5, 2013, Pages 297-301

  Feng, Pei ^a   Niu, Xiaohu ^a   Hu, Jianwei ^b   Zhou, Mo ^a   Liang, Hui ^a   Zhang, Yonghong ^a   Tong, Weijun ^a   Xu, Tan ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Department of People's Health   (China)

Author keywords

Acute ischemic stroke; Serum magnesium concentration; Short term outcome

Indexed keywords

CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; POTASSIUM;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAIN ISCHEMIA; CALCIUM BLOOD LEVEL; CONCENTRATION (PARAMETERS); CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; FAMILY HISTORY; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; RISK FACTOR; SMOKING;

BIOLOGICAL MARKERS; BRAIN ISCHEMIA; FEMALE; HUMANS; HYPERTENSION; MAGNESIUM; MALE; MIDDLE AGED; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84884691984     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.759696     Document Type: Article

References (33)

1. WHO. G lobal Burden of Disease 2002: Deaths by age, sex and cause for the year 2002. Geneva: World Health Organization; 2003
2. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005; 353: 1124-1134
3. Meairs S, Wahlgren N, Dirnagl U, Lindvall O, Rothwell P, Baron JC, et al. Stroke research priorities for the next decade-A representative view of the European scientifi c community. Cerebrovasc Dis. 2006; 22: 75-82
4. Jiang B, Wang W Z, Chen H, Hong Z, Yang Q D, Wu S P, et a l. Incidence and trends of stroke and its subtypes in China: Results from three large cities. Stroke. 2006; 37: 63-68
5. Huang R, Lee AH, Hu D, Binns C W. Hospitalizations for incident stroke in Shunde District, Foshan, South China. Neuroepidemiology. 2008; 30: 101-104
6. Zhang Y, Reilly K H, Tong W, Xu T, Chen J, Bazzano L A, et a l. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008; 26: 1446-1452
7. Stewart D, Marder VJ, Starkman S, Saver JL. Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activatorinduced thrombolysis. J Thromb Haemost. 2006; 4: 1575-1579
8. Muir K W. Magnesium for neuroprotection in ischaemic stroke: Rationale for use anDevidence of effectiveness. CNS Drugs. 2001; 15: 921-930
9. Liang W, Lee A H, Binns CW. D ietary intake of minerals and the risk of ischemic stroke in Guangdong Province, China, 2007-2008. Prev Chronic Dis. 2011; 8: A38
10. Larsson S C, Orsini N, Wolk A. D ietary magnesium intake and risk of stroke: A meta-Analysis of prospective studies. Am J Clin Nutr. 2012; 95: 362-366
11. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2009; 169: 1437-1344
12. Shafqat S, Kvedar J C, Guanci M M, Chang Y, Schwamm L H. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke. 1999; 30: 2141-2145
13. The writing group of acute ischemic stroke diagnosis and treatment guideline in Chinese Medical Academy of Neurology. Acute ischemic stroke diagnosis and treatment guideline in China. Chin J Neurol. 2010; 43: 146-152
14. Prevention guide of dyslipidemia in chinese adults. C hin J Cardiol. 2007; 35: 390-419
15. Alberti K, Zimmet P. Defi nition, diagnosis and classifi cation of diabetes mellitus and its complications. Part 1: Diagnosis and classifi cation of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553
16. Ma J, Folsom AR, Melnick S L, Eckfeldt J H, Sharrett AR, Nabulsi AA, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995; 48: 927-940
17. Amighi J, Sabeti S, Schlager O, Mlekusch W, Exner M, Lalouschek W, et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke. 2004; 35: 22-27
18. Kaluza J, Orsini N, Levitan E B, Brzozowska A, Roszkowski W, Wolk A. Dietary calcium and magnesium intake and mortality: A prospective study of men. Am J Epidemiol. 2010; 171: 801-807
19. Reffelmann T, Ittermann T, Dör r M, Völ zke H, Reinthaler M, Petersmann A, et al. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011; 219: 280-284
20. Ferrè S, Mazur A, Maier JA. L ow-magnesium induces senescent features in cultured human endothelial cells. Magnes Res. 2007; 20: 66-71
21. Wolf FI, Trapani V, Simonacci M, Ferr é S, Maier JA. M agnesium defi ciency anDendothelial dysfunction: Is oxidative stress involved? Magnes Res. 2008; 21: 58-64
22. Shechter M, Merz CN, Rude RK, Paul Labrador MJ, Meisel SR, Shah PK, et al. Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Am Heart J. 2000; 140: 212-218
23. Jee SH, Miller ER 3rd, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: A meta-Analysis of randomized clinical trials. Am J Hypertens. 2002; 15: 691-696
24. Bo S, Pisu E. R ole of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol. 2008; 19: 50-56
25. Uzui H, Lee JD. R ole of magnesium in hypertension therapy. Clin Calcium. 2005; 15: 117-122
26. Schanne FA, Gupta RK, Stanton PK. 3 1P-NMR study of transient ischemia in rat hippocampal slices in vitro. Biochim Biophys Acta. 1993; 28: 1158:257-263
27. Audebert HJ, Pellkofer T S, Wimmer ML, Haberl RL. Progression in lacunar stroke is related to elevated acute phase parameters. Eur Neurol. 2004; 51: 125-131
28. Katan M, Elkind MS. I nfl ammatory and neuroendocrine biomarkers of prognosis after ischemic stroke. Expert Rev Neurother. 2011; 11: 225-239
29. Sander D, Winbeck K, Klingelh öf er J, Etgen T, Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology. 2001, 11: 833-838
30. Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude RK. Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium defi ciency. J Am Coll Nutr. 1989; 8: 580-587
31. Appel SA, Molshatzki N, Schwammenthal Y, Merzeliak O, Toashi M, Sela BA, et al. Serum calcium levels and long-Term mortality in patients with acute stroke. Cerebrovasc Dis. 2011; 31: 93-99
32. Ascherio A, Rimm E B, Hern án M A, Giovannucci E L, Kawachi I, Stampfer MJ, et al. Intake of potassium, magnesium, calcium, and fi ber and risk of stroke among US men. Circulation. 1998; 98: 1198-1204
33. Musso CG. M agnesium metabolism in health and disease. I nt Urol Nephrol. 2009; 41: 357-362